Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity

NCT02183883 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02183883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02183883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Completed
Start date
December 16, 2016
Completion date
March 22, 2023
Enrollment
12 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer